PEDEVCO Corp. PED 深 滬
等待開盤 12-22 09:30:00 美东时间
0.5353
-0.012
-2.12%
華盛通- 最 高0.575
- 今 開0.575
- 成交量 10.75万股
- 最 低 0.51
- 昨 收 0.5469
- 總市值 5113.15万
- 52周最高 0.9988
- 市盈率 靜 3.88
- 換手率 0.11%
- 52周最低 0.4318
- 委 比 -85.19%
- 總股本 9551.94万
- 歷史最高 50.00
- 量 比 0.59
- 振 幅 11.89%
- 歷史最低 0.02
- 每 手 1
- 風險率 0.10%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多PEDEVCO Q3 Sales $6.961M Miss $7.758M Estimate
PEDEVCO (AMEX:PED) reported quarterly sales of $6.961 million which missed the analyst consensus estimate of $7.758 million by 10.28 percent. This is a 23.08 percent decrease over sales of $9.050 million the same period
11-17 19:59
PEDEVCO Announces Closing of Transformative Merger to Become Premier Rockies Operator
PEDEVCO announces merger with Juniper Capital’s portfolio companies, acquiring oil-weighted assets in Northern DJ and Powder River Basins. PEDEVCO issued 10.65 million Series A Convertible Preferred Shares, convertible into 106.5 million common shares, and refinanced portfolio debt. The transaction positions PEDEVCO as a leading Rockies-focused operator with ~6,500 BOEPD production and 328,000 net acres, supported by low-cost operations and exten...
11-04 17:31
Eli Lilly And Incyte's Baricitinib Delivers One-Year Hair Regrowth In Adolescents With Severe Alopecia Areata; BRAVE-AA-PEDS Data To Be Presented At 2025 FCD Conference
This trial is the first and largest study specifically designed to evaluate children and adolescents with severe alopecia areata, a population often underrepresented in clinical trials New data show 71% of
10-24 18:55
华东医药战略合作伙伴Arcutis宣布ZORYVE乳膏（0.05%）sNDA获美国FDA批准
（来源：华东医药股份有限公司） 转自：华东医药股份有限公司 近日，华东医药股份有限公司全资子公司杭州中美华东制药有限公司美国合作方 Arcutis Bioth...
10-13 16:34
Eli Lilly Announces Results From SURPASS-PEDS, The First Phase 3 Trial To Evaluate The Safety And Efficacy Of Mounjaro; Mounjaro Met The Primary And All Key Secondary Endpoints At 30 Weeks And Showed Sustained Improvement In Glycemic Control And Continued BMI Reduction Through The Study's 52-Week Extension; The Safety And Tolerability Profile Of Mounjaro Was Generally Consistent With Previous Adult Studies
INDIANAPOLIS, Sept. 17, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced detailed results from SURPASS-PEDS, the first Phase 3 trial to evaluate the safety and efficacy of Mounjaro (tirzepatide), a
09-18 06:05
中集集团（000039.SZ/02039.HK）：中期净利润和现金流实现大幅增长，业务重构与价值深耕深刻改变公司估值逻辑
8月27日，中集集团（000039.SZ/02039.HK）发布2025年半年报。透过这份新鲜出炉的半年报，中集集团的经营成绩跃然纸上数据显示，上半年公司实现收...
09-09 14:33
中东金主加注 普洛斯靠新经济再获15亿美元投资
（来源：观点网） 观点网 在算力引入战投后，普洛斯又获得中东金主的大手笔投资。 8月28日，普洛斯集团对外宣布，获得阿布扎比投资局（"ADIA"）全资子公司...
08-29 00:10
迈为股份：8月22日接受机构调研，BARNHILL CAPITAL LIMITED、宝盈基金管理有限公司等多家机构参与
证券之星消息，2025年8月24日迈为股份（300751）发布公告称公司于2025年8月22日接受机构调研，BARNHILL CAPITAL LIMITED、宝盈基金管理有限公司、上海五地私募基金管理有限公司、上海益和源资产管理有限公司、上海云门投资管理有限公司、上海匀升投资管理有限公司、上海重阳投资管理股份有限公司、深圳宏鼎财富管理有限公司、深圳前海旭鑫资产管理有限公司、深圳...
08-24 20:30
【瑞普生物】国内经济动物mRNA疫苗取得突破，推动动物mRNA技术应用进入新阶段...
2025 热烈祝贺 闪耀获批 近日，瑞普生物宣布，公司开发的猪流行性腹泻mRNA疫苗已获得农业农村部批复的临床试验许可。这一进展标志着养殖业防疫技术取得重要进步...
08-22 13:51
